Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnilever Regulatory News (ULVR)

Share Price Information for Unilever (ULVR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,278.00
Bid: 4,063.00
Ask: 4,330.00
Change: 0.00 (0.00%)
Spread: 267.00 (6.571%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 4,278.00
ULVR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Unilever simplifies organisation

25 Jan 2022 09:00

RNS Number : 5509Z
Unilever PLC
25 January 2022
 

Unilever simplifies organisation

 

 

London, 25 January 2022. Unilever today announced changes to its organisational model to make it a simpler, more category-focused business.

 

The company will move away from its current matrix structure and will be organised around five distinct Business Groups: Beauty & Wellbeing, Personal Care, Home Care, Nutrition, and Ice Cream. Each Business Group will be fully responsible and accountable for their strategy, growth, and profit delivery globally.

 

Alan Jope, CEO Unilever, explains, "Our new organisational model has been developed over the last year and is designed to continue the step-up we are seeing in the performance of our business. Moving to five category-focused Business Groups will enable us to be more responsive to consumer and channel trends, with crystal-clear accountability for delivery. Growth remains our top priority and these changes will underpin our pursuit of this."

 

To enable Unilever to benefit from its scale and global capabilities, the five Business Groups will be supported by Unilever Business Operations, which will provide the technology, systems, and processes to drive operational excellence across the business. A lean Unilever Corporate Centre will continue to set Unilever's overall strategy.

 

As a result of the new set-up, Unilever is making changes to its leadership team.

 

· Fernando Fernandez, EVP Latin America, has been appointed President Beauty & Wellbeing, which includes Hair Care, Skin Care, as well as Vitamins, Minerals and Supplements, and Unilever Prestige.

· Fabian Garcia, President North America, has been appointed President Personal Care, responsible for Skin Cleansing, Deodorants, and Oral Care.

· Peter ter Kulve will continue in his role as President Home Care, responsible for Fabric Care, Home & Hygiene, and Water & Air.

· Hanneke Faber, President Foods & Refreshment, has been appointed President Nutrition, which will be home to Scratch Cooking, Healthy Snacking, Functional Nutrition, Plant-Based Meat, and Food Solutions.

· Matt Close, EVP Ice Cream, has been appointed President Ice Cream, a Business Group in its own right.

 

These appointments are effective from April 1, 2022.

 

In addition:

 

· Nitin Paranjpe, Chief Operating Officer (COO), will take on a new role as Chief Transformation Officer & Chief People Officer, leading the business transformation, and heading the HR function.

· Reginaldo Ecclissato, Chief Supply Chain Officer, will lead the Supply Chain and Unilever Business Operations as Chief Business Operations Officer.

 

Sunny Jain, President Beauty & Personal Care, has decided to leave Unilever to set up an investment fund in technology megatrends. Other members of the Unilever Leadership Executive (ULE) will remain in role, including Sanjiv Mehta who will retain executive leadership of Hindustan Unilever.

 

The proposed new organisation model will result in a reduction in senior management roles of around 15% and more junior management roles by 5%, equivalent to around 1,500 roles globally. Changes will be subject to consultation. We do not expect factory teams to be impacted by these changes.

 

All costs related to setting up the new organisation will be managed within existing restructuring investment plans.

 

ENDS

 

 

Enquiries

Media:

press-office.london@unilever.com

Jonathan Sibun +44 7779 999 683 / JSibun@tulchangroup.com

Lucila Zambrano +44 7825 273 767 / lucila.zambrano@unilever.com

 

Investors:

Investor Relations Team +44 20 7822 6830 investor.relations@unilever.com

 

 

About Unilever  

 

Unilever is one of the world's leading suppliers of Beauty & Personal Care, Home Care, and Foods & Refreshment products, with sales in over 190 countries and products used by 2.5 billion people every day. We have 149,000 employees and generated sales of €50.7 billion in 2020.  

Our vision is to be the global leader in sustainable business and to demonstrate how our purpose-led, future-fit business model drives superior performance. We have a long tradition of being a progressive, responsible business.  

The Unilever Compass, our sustainable business strategy, is set out to help us deliver superior performance and drive sustainable and responsible growth, while: 

- improving the health of the planet;  

- improving people's health, confidence and wellbeing; and  

- contributing to a fairer and more socially inclusive world. 

For more information about Unilever and our brands, please visit www.unilever.com.  

 

 

Safe Harbour

 

This announcement may contain forward-looking statements, including 'forward-looking statements' within the meaning of the United States Private Securities Litigation Reform Act of 1995. Words such as 'will', 'aim', 'expects', 'anticipates', 'intends', 'looks', 'believes', 'vision', or the negative of these terms and other similar expressions of future performance or results, and their negatives, are intended to identify such forward-looking statements. These forward-looking statements are based upon current expectations and assumptions regarding anticipated developments and other factors affecting the Unilever Group (the 'Group'). They are not historical facts, nor are they guarantees of future performance.

 

Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements. Among other risks and uncertainties, the material or principal factors which could cause actual results to differ materially are: Unilever's global brands not meeting consumer preferences; Unilever's ability to innovate and remain competitive; Unilever's investment choices in its portfolio management; the effect of climate change on Unilever's business; Unilever's ability to find sustainable solutions to its plastic packaging; significant changes or deterioration in customer relationships; the recruitment and retention of talented employees; disruptions in our supply chain and distribution; increases or volatility in the cost of raw materials and commodities; the production of safe and high quality products; secure and reliable IT infrastructure; execution of acquisitions, divestitures and business transformation projects; economic, social and political risks and natural disasters; financial risks; failure to meet high and ethical standards; and managing regulatory, tax and legal matters. A number of these risks have increased as a result of the current Covid-19 pandemic. These forward-looking statements speak only as of the date of this document. Except as required by any applicable law or regulation, the Group expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Group's expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

 

Further details of potential risks and uncertainties affecting the Group are described in the Group's filings with the London Stock Exchange, Euronext Amsterdam and the US Securities and Exchange Commission, including in the Annual Report on Form 20-F 2020 and the Unilever Annual Report and Accounts 2020 available on our corporate website.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFIFSTLIIEFIF
Date   Source Headline
27th Mar 20235:18 pmRNSTransaction in Own Shares
27th Mar 20233:20 pmRNSDirector/PDMR Shareholding
24th Mar 20235:09 pmRNSTransaction in Own Shares
24th Mar 20234:57 pmRNSDirector/PDMR Shareholding
24th Mar 20234:38 pmRNSTransaction in Own Shares
24th Mar 20234:30 pmRNSTransaction in Own Shares
24th Mar 20234:21 pmRNSTransaction in Own Shares
24th Mar 20232:50 pmRNSDirector/PDMR Shareholding
23rd Mar 20235:00 pmRNSTransaction in Own Shares
23rd Mar 202311:47 amRNSDirector/PDMR Shareholding
22nd Mar 20235:06 pmRNSTransaction in Own Shares
21st Mar 20234:52 pmRNSTransaction in Own Shares
20th Mar 20234:54 pmRNSTransaction in Own Shares
20th Mar 20232:59 pmRNSNotice of AGM
17th Mar 20235:06 pmRNSTransaction in Own Shares
17th Mar 20234:31 pmRNSDirector/PDMR Shareholding
17th Mar 20237:45 amRNSShare Buy-Back Programme
14th Mar 20234:06 pmRNSDirector/PDMR Shareholding
13th Mar 20236:20 pmRNSAnnual Report on Form 20-F
10th Mar 20235:47 pmRNSDirector/PDMR Shareholding
9th Mar 20236:22 pmRNSAnnual Financial Report
3rd Mar 202310:49 amRNSTotal Voting Rights
2nd Mar 20239:19 amRNSDirectorate Change
17th Feb 20234:38 pmRNSDirector/PDMR Shareholding
14th Feb 20235:51 pmRNSDirector/PDMR Shareholding
10th Feb 20236:03 pmRNSDirector/PDMR Shareholding
10th Feb 20234:49 pmRNSDirector/PDMR Shareholding
9th Feb 20237:00 amRNSFinal Results
2nd Feb 20231:22 pmRNSTotal Voting Rights
30th Jan 20237:00 amRNSDirectorate Change
13th Jan 202312:06 pmRNSPDMR Shareholding
4th Jan 202312:59 pmRNSTotal Voting Rights
20th Dec 20223:07 pmRNSPDMR Shareholding
19th Dec 20225:48 pmRNSDirector/PDMR Shareholding
19th Dec 20225:45 pmRNSShare Buyback Programme
19th Dec 20225:38 pmRNSTransaction in Own Shares
16th Dec 20226:05 pmRNSTransaction in Own Shares
15th Dec 20226:07 pmRNSTransaction in Own Shares
15th Dec 20225:35 pmRNSDirector/PDMR Shareholding
15th Dec 20223:04 pmRNSBlock listing of Shares
14th Dec 20226:12 pmRNSTransaction in Own Shares
13th Dec 20226:02 pmRNSTransaction in Own Shares
13th Dec 20223:59 pmRNSDirector/PDMR Shareholding
13th Dec 20222:40 pmRNSDirector/PDMR Shareholding
12th Dec 20225:51 pmRNSTransaction in Own Shares
12th Dec 202212:47 pmRNSDirector/PDMR Shareholding
9th Dec 20225:28 pmRNSTransaction in Own Shares
8th Dec 20226:14 pmRNSTransaction in Own Shares
7th Dec 20226:05 pmRNSTransaction in Own Shares
7th Dec 20224:54 pmRNSCapital Markets Day

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.